Mexico Pharma IPO Joins BMV Reopening

Mexico Pharma IPO Joins BMV Reopening

Equity

An IPO for Mexican pharmaceuticals distributor Genomma Lab Internacional is heard in the works, targeting a raise above $300m. IXE and Santander are running the deal locally, with Merrill Lynch and UBS leading the international effort. Up to 184m sha

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial